Chronic Kidney Disease & Cystatin C: Latest Data Allows Better Risk Selection with the Ability to Issue More Cases

February 15, 2022

The conclusions of the Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference were recently published.1 This expert panel started with… Read More

Tags: eGFR, Kidney, Life Insurance, Mortality, Risk